New drug aims to preserve Insulin-Making cells in type 1 diabetes
NCT ID NCT07493122
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a new drug called IMC-S118AI in people with type 1 diabetes who have a specific genetic marker (HLA-A*02:01). The main goal is to check if the drug is safe and how it works in the body. Researchers will also look at whether it can help preserve the cells that make insulin. About 154 participants will take part in this early-stage trial.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETES TYPE 1 are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can an app and cash rewards tame type 1 diabetes in young adults?
- Can Open-Source insulin systems match commercial ones without meal announcements?
- Smart insulin pump aims to end dangerous nighttime blood sugar swings
- Could diabetes be silently damaging your hearing?
- Hidden liver risk in type 1 diabetes: a new study investigates
- A glucose Monitor's second chance: can it tame type 1 diabetes in High-Risk teens?